Bilirubin-induced neurologic dysfunction (BIND)

Seminars in Fetal and Neonatal Medicine

Volumn 20, Issue 1, 2015, Pages 1-

  Bhutani, Vinod K ^a   Wong, Ronald ^b  

^a LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

AMYGDALOID NUCLEUS; AUTISM; BILIRUBIN INDUCED NEUROLOGIC DYSFUNCTION; BRAIN GROWTH; BRAIN INJURY; BRAIN MATURATION; BRAIN REGION; CAUDATE NUCLEUS; CELL DAMAGE; CELL MIGRATION; CELL NUCLEUS INCLUSION BODY; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CEREBRAL PALSY; CLINICAL DECISION MAKING; COMORBIDITY; CONSENSUS; DISEASE SEVERITY; EDITORIAL; ENDOTHELIUM CELL; ENVIRONMENTAL FACTOR; EXECUTIVE FUNCTION; GESTATIONAL AGE; GLOBUS PALLIDUS; GRAY MATTER; HIGH RISK POPULATION; HIPPOCAMPUS; HUMAN; HYPERBILIRUBINEMIA; KERNICTERUS; LEARNING; MICROGLIA; MOTOR PERFORMANCE; MUSCLE TONE; NEUROLOGIC DISEASE; NEUROTOXICITY; PERCEPTION; PUTAMEN; REWARD; SCHIZOPHRENIA; SENSATION; BLOOD; COMPLICATION; NEONATAL HYPERBILIRUBINEMIA; NEWBORN; RISK FACTOR;

HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; KERNICTERUS; RISK FACTORS;

EID: 84922926792     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2014.12.010     Document Type: Editorial

References (0)